WB
XERS icon

Webster Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Webster Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Sell
1,900
-1,100
-37% -$7.29K ﹤0.01% 513
2025
Q4 		$23.6K Sell
3,000
-1,000
-25% -$7.87K ﹤0.01% 432
2025
Q3 		$32.6K Buy
4,000
+1,000
+33% +$6.64K ﹤0.01% 403
2025
Q2 		$14K Hold
3,000
– – ﹤0.01% 467
2025
Q1 		$16.5K Buy
+3,000
New +$12.1K ﹤0.01% 446

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Webster Bank's XERS Position: Q1 2026 in Review

Webster Bank reduced its Xeris Biopharma Holdings (XERS) stake by 37% in Q1 2026, selling an estimated $7.29K and leaving 1,900 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Webster Bank first reported a position in XERS in Q1 2025 and has held it in 5 quarters since. The position peaked at $32.6K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Webster Bank held 1,900 shares of Xeris Biopharma Holdings worth $11K as of Q1 2026.
  • Webster Bank sold 1,100 Xeris Biopharma Holdings shares in Q1 2026, an estimated $7.29K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Webster Bank's portfolio in Q1 2026, its #513 holding.
  • Webster Bank first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 5 quarters since.
  • Webster Bank's Xeris Biopharma Holdings position peaked at $32.6K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Webster Bank's 13F filing for Q1 2026, filed 17 Apr 2026.